This week we cover the latest COVID-19 developments including: reports of false negatives with Abbott’s diagnostic test; the immune globulin therapy linked to recovery in multisystem inflammatory syndrome in children, related to COVID-19; and the clinical trials set to be initiated for an umbilical cord stem cell therapy and a high dose IV immune globulin therapy.